Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $275K 6,348 sh | Sep 3, 2026 |
| 14 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $746K 17.4K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $8,177 3,618 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $4,793 2,121 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 14 | Radhakrishnan SrikanthChief Science & Techn. Officer | Open-market sale | SELL | $5,973 2,643 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 13 | Enguent Jean-PierreVice President, R&DSS | Open-market sale · 10b5-1 plan | SELL | $36K 15.0K sh | Sep 3, 2026 traded Sep 3, 2026 |
| 13 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $48K 6,862 sh | Sep 3, 2026 traded Aug 28, 2026 |
| 12 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $767K 7,215 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 11 | Barrett CherieSVP, Chief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $421K 3,985 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $89K 1,090 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 10 | Hawkins Matthew J.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $2.14M 82.5K sh | Sep 3, 2026 traded Sep 2, 2026 |
| 10 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $109K 1,344 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 9 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $965K 22.8K sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $320K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $449K 1,400 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Randhawa SimratEVP, Head of R&D | Open-market sale · 10b5-1 plan | SELL | $273K 2,600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $37K 858 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 7 | Le Pendeven YvesCFO | Open-market sale · 10b5-1 plan | SELL | $12K 1,833 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $477K 3,882 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 7 | Colburn Richard Edward IIIChief Product & Tech Officer | Open-market sale · 10b5-1 plan | SELL | $40K 479 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $59K 1,368 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $193K 600 sh | Sep 3, 2026 traded Sep 1, 2026 |
| 3 | Roth James MChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $392 94 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 3 | McGrane AshleyGeneral Counsel and Corp Sec | Open-market sale · 10b5-1 plan | SELL | $142 34 sh | Sep 3, 2026 traded Sep 2, 2026 |
| 1 | Arora TarunChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $73K 954 sh | Sep 3, 2026 traded Sep 3, 2026 |
| 49 | Sheldon WhitehouseDSelf | sell | SELL | $15K – $50K | Sep 2, 2026 traded Aug 13, 2026 |
| 45 | Sheldon WhitehouseDSpouse | sell | SELL | $1,001 – $15K | Sep 2, 2026 traded Aug 13, 2026 |
| 42 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $1.55M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $1.55M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $1.54M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 42 | Liu ChiDirector, Chief Executive Officer | Open-market sale | SELL | $132K 23.8K sh | Sep 2, 2026 traded Aug 31, 2026 |
| 42 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $1.54M 40.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 40 | Sheldon WhitehouseDSpouse | sell | SELL | $1,001 – $15K | Sep 2, 2026 traded Aug 13, 2026 |
| 39 | Zhou ShengleiDirector | Open-market sale | SELL | $36K 6,548 sh | Sep 2, 2026 traded Aug 31, 2026 |
| 37 | John J. McGuire IIIRSpouse | Partial sale | SELL | $1,001 – $15K | Sep 2, 2026 traded Aug 18, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $770K 19.8K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $770K 19.8K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 35 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale | SELL | $771K 20.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 35 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale | SELL | $771K 20.0K sh | Sep 2, 2026 traded Sep 1, 2026 |
| 35 | Fang XingDirector | Open-market sale | SELL | $8,716 1,568 sh | Sep 2, 2026 traded Aug 31, 2026 |